Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Niyazi Volkan Demircan"'
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology, Vol 31, Iss , Pp 100268- (2024)
Purpose: The aim of this study is to investigate, from a dosimetric perspective, whether helical Tomotherapy (HT) during free breathing (FB) can serve as an alternative technique for treating left-sided breast cancer patients who are unable to comply
Externí odkaz:
https://doaj.org/article/8c78b1b934d74c32b117d9a82bf6a7c4
Autor:
Niyazi Volkan Demircan, Nuran Bese
Publikováno v:
European Journal of Breast Health, Vol 20, Iss 1, Pp 1-7 (2024)
Breast cancer stands as the most prevalent malignancy, necessitating a well-established approach to its management due to its sustained prevalence over decades. The implementation of intensive treatments, combining various modalities, has yielded exc
Externí odkaz:
https://doaj.org/article/7ddc34ee5dff434490c27b2d3803fcbf
Autor:
Diclehan Kılıç, Oya Akyol, Niyazi Volkan Demircan, Muhammed Ertuğrul Şentürk, Serap Çatlı Dinç
Publikováno v:
Genel Tıp Dergisi, Vol 29, Iss 3, Pp 124-129 (2019)
Amaç: Meme kanseri görülme sıklığı yıllar içerisinde artmasına rağmen meme kanserine bağlı ölüm oranlarında belirgin azalma dikkat çekmektedir. Buna bağlı olarak artan genel sağkalım süreleri, meme kanseri tedavisinde görülen
Externí odkaz:
https://doaj.org/article/a8a21ce5dabd4e9cb5a8de3d5147d44b
Autor:
Niyazi Volkan Demircan, Ozge Petek Erpolat, Caglar Guzel, Ertugrul Senturk, Huseyin Bora, Eray Karahacioglu
Publikováno v:
Turkish Neurosurgery.
Autor:
Aybala Nur Turan, Muhammed Ertugrul Senturk, Eray Karahacioglu, Serap Catli Dinc, Huseyin Bora, Niyazi Volkan Demircan
Publikováno v:
Selcuk Tip Dergisi. 1:33-38
Amac: Bu calisma, Eclipse tedavi planlama sistemi kullanilarak, genisletilmis kaynak cilt mesafesindeki iki tum vucut isinlama teknigi (TBI) icin risk altindaki organ dozlarini karsilastirmaktadir. Gerec ve Yontemler: Bilateral TBI uygulanan 20 hasta
Autor:
Pelin Kuzucu, Niyazi Volkan Demircan, Gulistan Sanem Saribas, Alp Özgün Börcek, Ozge Petek Erpolat, Çiğdem Elmas, Ertugrul Senturk, Gökhan Kurt
Background: Bevacizumab, an anti-vascular endothelial growth factor (VEGF) antibody, is a new treatment approach for radionecrosis. In our study, we compared the prophylactic and therapeutic usage of a promising agent, ramipril (an angiotensin-conver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::538c257a67787bf6186d5d0eb953f5df
https://avesis.gazi.edu.tr/publication/details/00d1d7ab-5c01-4df2-b33b-b998fb6620ae/oai
https://avesis.gazi.edu.tr/publication/details/00d1d7ab-5c01-4df2-b33b-b998fb6620ae/oai
Autor:
Serap Çatli Dinç, Niyazi Volkan Demircan, Muhammed Ertugrul Senturk, Oya Akyol, Diclehan Kiliç
Amaç: Meme kanseri görülme sıklığı yıllar içerisinde artmasına rağmen meme kanserine bağlı ölüm oranlarında belirgin azalma dikkat çekmektedir. Buna bağlı olarak artan genel sağkalım süreleri, meme kanseri tedavisinde görülen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb5e7ad446acaeed6142b39a56a494fd
https://avesis.gazi.edu.tr/publication/details/f21b9433-4c30-44a5-80e0-6a94c5428e58/oai
https://avesis.gazi.edu.tr/publication/details/f21b9433-4c30-44a5-80e0-6a94c5428e58/oai